Top 20 Companies in The Global Parenteral Nutrition Market: Global Share, Market Size, Revenue Report (2024–2035)
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Parenteral Nutrition Market Size is projected to grow from USD 7.94 Billion in 2024 to USD 14.91 Billion by 2035, at a CAGR of 5.9% during the forecast period 2024–2035. a Market growth is driven by increasing prevalence of chronic diseases, rising demand for clinical nutrition support, growing geriatric population, and expanding hospital care infrastructure globally. Additionally, advancements in lipid emulsions, personalized nutrition formulations, and home-based parenteral nutrition solutions are enhancing treatment outcomes and patient convenience.
Introduction
Parenteral nutrition (PN) is a medical method of delivering nutrients directly into the bloodstream, bypassing the digestive system. It is used for patients who cannot consume or absorb food orally or enterally due to conditions such as gastrointestinal disorders, cancer, or critical illness. PN formulations typically include amino acids, lipids, carbohydrates, vitamins, and minerals. The parenteral nutrition market is growing due to the increasing incidence of malnutrition, preterm births, chronic diseases such as cancer and gastrointestinal disorders, and advances in technology, e.g., sterile compounding technologies, multi-compartment bags for parenteral nutrition, and changes in government policies. Governments around the world are increasing their investments in healthcare and clinical nutrition to help develop and implement increasingly technology-driven clinical nutrition therapies.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Parenteral Nutrition Market.
Global Parenteral Nutrition Market Size, Share, and By Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion, Vitamins & Minerals), By Stage Type (Adult, Pediatric), By Indication, By Sales Channel (Online, Retail), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2024 - 2035
Global Parenteral Nutrition Market Size & Statistics
- The Market Size for the Global Parenteral Nutrition Market Was Estimated to be worth USD 7.94 Billion in 2024.
- The Global Parenteral Nutrition Market is going to expand at a CAGR of 5.9% between 2024 and 2035.
- The Global Parenteral Nutrition Market Size is anticipated to reach USD 14.91 Billion by 2035.
- Asia Pacific is expected to generate the highest revenue during the forecast period in the Global Parenteral Nutrition Market.
- North America is expected to grow the fastest during the forecast period in the Global Parenteral Nutrition Market

Regional growth and demand
Asia is expected to generate the highest revenue during the forecast period in the global parenteral nutrition market. Asia Pacific is expected to dominate the parenteral nutrition market due to rapid healthcare expansion and product innovation. In 2023, Baxter Korea launched Olimel N12E, while JW Holdings expanded exports of multi-chamber PN solutions, strengthening regional supply and accessibility.
North America is expected to grow at faster rate during the forecast period in the global parenteral nutrition market. North America is one of the fastest-growing regions in the parenteral nutrition market due to advanced healthcare infrastructure and strong clinical adoption. In 2024, increasing uptake of multi-chamber PN formulations and expansion of home infusion programs significantly improved accessibility and outpatient nutrition care across the region.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Parenteral Nutrition Market.
Ready to lead the Parenteral Nutrition Market?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 trends in the Global Parenteral Nutrition Market
- Rising demand for home parenteral nutrition (HPN)
- Growth in personalized and patient-specific nutrition formulations
- Increasing adoption of multi-chamber bag systems
- Advancements in lipid emulsions (fish oil-based, SMOF lipids)
- Expansion of neonatal and pediatric nutrition solutions
- Integration of automated compounding systems
- Focus on infection control and sterile manufacturing
- Growth in oncology-related nutritional support
- Increasing regulatory approvals for advanced formulations
- Rising partnerships between hospitals and nutrition providers
1. Rising Demand for Home Parenteral Nutrition (HPN)
Home Parenteral Nutrition enables patients with chronic gastrointestinal disorders to receive long-term nutritional support outside hospitals. This reduces hospitalization costs and improves patient quality of life. Growth is driven by increasing chronic disease prevalence and advancements in portable infusion systems.
2. Growth in Personalized and Patient-Specific Nutrition Formulations
Hospitals are increasingly adopting customized parenteral nutrition tailored to individual patient needs based on age, disease condition, and metabolic requirements. This improves clinical outcomes, reduces complications, and supports precision medicine trends in healthcare.
3. Increasing Adoption of Multi-Chamber Bag Systems
Advancements in metal additive manufacturing (DMLS, SLM) are driving the production of durable metal prototypes for critical applications in aerospace and automotive sectors, with metal-based prototyping expected to be a fast-growing segment.
4. Advancements in Lipid Emulsions (Fish Oil-Based, SMOF Lipids)
Environmental concerns are driving the adoption of sustainable materials, including bio-based polymers and recycled materials. This aligns with global regulations, focusing on material circularity, such as reusable powders and spools.
5. Expansion of Neonatal and Pediatric Nutrition Solutions
Increasing preterm births and pediatric malnutrition are driving demand for specialized parenteral nutrition formulations. These solutions are designed to meet precise growth and developmental needs, supporting improved survival rates and long-term health outcomes in infants and children.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the global parenteral nutrition market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Parenteral Nutrition Market.
Top 25 Companies Leading the Global Parenteral Nutrition Market.
- Baxter International Inc.
- Fresenius Kabi AG
- B. Braun Melsungen AG
- Pfizer Inc.
- Grifols S.A.
- Otsuka Pharmaceutical Co., Ltd.
- Ajinomoto Co., Inc.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- JW Pharmaceutical Corporation
- Vifor Pharma (CSL Vifor)
- Nestlé Health Science
- Danone Nutricia
- ICU Medical, Inc.
- Terumo Corporation
- Claris Lifesciences Limited
- Aculife Healthcare Pvt. Ltd.
- Albert David Limited
- Pharamed Healthcare
- Baxter Healthcare (regional divisions)
- Fresenius SE & Co. KGaA
- Hospira (Pfizer subsidiary)
- Otsuka Holdings Co., Ltd.
- Sino-Swed Pharmaceutical Corp.
- Kelun Group
- Beximco Pharmaceuticals Ltd.
1. Baxter International Inc
Headquarters: USA, Switzerland
Baxter International Inc. is a global leader in clinical nutrition, offering a wide portfolio of parenteral nutrition solutions including premixed multi-chamber bags and customized compounding systems. The company generates approximately USD 14.8 billion in annual revenue. In 2024, Baxter expanded its PN portfolio with enhanced ready-to-use formulations, focusing on hospital and home care settings.Baxter holds a leading share in the global PN market due to its end-to-end ecosystem (nutrition + delivery systems) and strong hospital partnerships.
2. B. Braun Melsungen AG
Headquarters: USA, Germany
B. Braun Melsungen AG provides comprehensive parenteral nutrition solutions including customized admixtures and infusion systems. The company generates approximately EUR 8.5 billion in annual revenue. In 2024, it strengthened its automated compounding technologies to improve safety and efficiency in hospital nutrition delivery. Strong in Europe with integrated solutions combining nutrition, devices, and hospital workflow optimization.
3. Fresenius Kabi AG
Headquarters: USA, Germany
Fresenius Kabi AG specializes in clinical nutrition, infusion therapies, and IV drugs, with a strong presence in parenteral nutrition products. The company generates approximately EUR 8.0 billion in revenue. In 2024, it expanded production capacity for lipid emulsions and amino acid solutions to meet growing global demand. Strong global footprint with leadership in Europe and expanding presence in Asia, driven by large-scale manufacturing and cost-efficient supply.
4. Pfizer Inc.
Headquarters: United Kingdom, USA
Pfizer Inc., through its Hospira division, offers sterile injectable products and parenteral nutrition components. The company generates approximately USD 58.5 billion in annual revenue. In 2024, Pfizer continued expanding its sterile injectables portfolio supporting hospital nutrition therapies. Market Positioning indirect but critical player in PN ecosystem through injectables and hospital supply infrastructure
5. Grifols S.A.
Headquarters: Spain, USA
Grifols S.A. focuses on plasma-derived medicines and hospital nutrition products. The company generates approximately EUR 6.6 billion in annual revenue. In 2024, it expanded its clinical nutrition offerings and hospital partnerships to strengthen its presence in parenteral nutrition. 2 headquarters of each. Emerging PN player with strong hospital integration strategy and growing footprint in Europe and developing markets.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Parenteral Nutrition Market.
Company Profiles
- Baxter International Inc.
•Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Mergers and Acquisitions
• SWOT Analysis
- Fresenius Kabi AG
- B. Braun Melsungen AG
- Pfizer Inc.
- Grifols S.A.
- Otsuka Pharmaceutical Co., Ltd.
- Ajinomoto Co., Inc.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- JW Pharmaceutical Corporation
- Vifor Pharma (CSL Vifor)
- Nestlé Health Science
- Danone Nutricia
- ICU Medical, Inc.
- Terumo Corporation
- Claris Lifesciences Limited
- Aculife Healthcare Pvt. Ltd.
- Albert David Limited
- Pharamed Healthcare
- Baxter Healthcare (regional divisions)
- Fresenius SE & Co. KGaA
- Hospira (Pfizer subsidiary)
- Otsuka Holdings Co., Ltd.
- Sino-Swed Pharmaceutical Corp.
- Kelun Group
- Beximco Pharmaceuticals Ltd.
Our Reports
https://www.sphericalinsights.com/reports/europe-anti-aging-supplements-market
https://www.sphericalinsights.com/reports/europe-ophthalmic-drugs-market
https://www.sphericalinsights.com/reports/europe-methanol-market
https://www.sphericalinsights.com/reports/germany-asphalt-pavers-market
https://www.sphericalinsights.com/reports/france-fertility-services-market
Conclusion
The global parenteral nutrition market is experiencing growth due to rising clinical demand, an increasing prevalence of chronic disease, and a larger ageing population requiring specific forms of nutrition. The market is benefiting from advancements in medical nutrition technology (improved lipid emulsions, multi-chamber bag systems; better automated compounding solutions) which promotes enhanced safety and efficiency in the provision of parenteral nutrition. North America has been and remains the largest market worldwide due to its established healthcare systems, high levels of healthcare expenditure, and early adoption of advanced clinical practices related to the administration of medical nutrition support. Conversely, Asia Pacific represents a newer and therefore rapidly developing market due to expanding access to the healthcare system; an increase in hospital infrastructure; and a substantial population requiring care. In addition, increasing education related to the consequences of malnutrition and the need for alternatives to traditional inpatient care solutions are creating momentum for future demand. Continuous innovation related to formulation technologies (personalised nutrition) and sterile manufacturing processes will ultimately improve treatment outcomes and contribute to long-term financial sustainability of the global parenteral nutrition industry through 2035.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?